{
    "code": "01031208",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01031208",
    "time": "2020-02-25 05:30:19",
    "許可證字號": "衛署藥製字第031208號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/01\/19",
    "發證日期": "78\/01\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103120800",
    "中文品名": "&quot;利達&quot;利胃健凍晶注射劑（匹雷辛平）",
    "英文品名": "LIZEPINE LYOPHILIZED INJECTION (PIRENZEPINE) &quot;LITA&quot;",
    "適應症": "胃、十二指腸潰瘍、緊張性潰瘍、病理性胃酸高度分泌狀況",
    "劑型": "243凍晶注射劑",
    "包裝": "100公絲安瓿 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 1G不得製造",
        "申請商名稱": "0701010200  利達製藥股份有限公司",
        "申請商地址": "台中市大甲區中山路一段９０６號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5626008515",
            "成分名稱": "PIRENZEPINE 2HCL (DIHYDRATE)",
            "含量描述": "(10.43 MG) 10",
            "含量": "",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010312080002.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01031208&Seq=002&Type=9"
        }
    ]
}